Clinical trial
The Utility of Next-generation Sequencing for the Diagnosis of Periprosthetic Joint Infection
NCT03200470 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Utility of Next-generation Sequencing for the Diagnosis of Periprosthetic Joint Infection
- Lead sponsor
- Rothman Institute Orthopaedics
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 16, 2017
- Completion date
- March 31, 2018
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prosthetic joint infection